企業プロフィール
Puma Biotechnology Inc 株価・ニュース・カタリスト
- ティッカー:
- PBYI
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
8.82 USD (-0.11%)
終値
最終更新: 2026年8月17日
355M USD
時価総額
株価変動の要因
As of Aug 17, 2026, PBYI was little changed and closed at $8.82. No new same-company headline was identified in the current news window.
企業概要
事業概要
Puma Biotechnology is an oncology company focused on breast-cancer therapy and targeted cancer medicines. Its business has long centered on a concentrated commercial oncology franchise.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Puma sits in specialty oncology biotechnology.
ビジネスモデルの特徴
The company depends on product revenue, market access, and the durability of its commercial cancer portfolio.
バイオ業界での位置付け
Puma is a commercial oncology name with limited breadth but meaningful sensitivity to product execution.
今後のカタリスト
- Puma Biotechnology’s catalysts are NERLYNX execution and any label / oncology update that extends the franchise. Investors will care about whether the commercial base can keep hanging on.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。